A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)
Venous thromboembolism (VTE) is prevalent and impactful, with a risk of death, morbidity and recurrence. Post‐thrombotic syndrome (PTS) is a common consequence and associated with impaired quality of life (QoL). The ExACT study was a non‐blinded, prospective, multicentred randomised controlled trial...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2019
|
| _version_ | 1826300703050563584 |
|---|---|
| author | Bradbury, C Fletcher, K Sun, Y Heneghan, C Gardiner, C Roalfe, A Hardy, P McCahon, D Heritage, G Shackleford, H Hobbs, F Fitzmaurice, D |
| author_facet | Bradbury, C Fletcher, K Sun, Y Heneghan, C Gardiner, C Roalfe, A Hardy, P McCahon, D Heritage, G Shackleford, H Hobbs, F Fitzmaurice, D |
| author_sort | Bradbury, C |
| collection | OXFORD |
| description | Venous thromboembolism (VTE) is prevalent and impactful, with a risk of death, morbidity and recurrence. Post‐thrombotic syndrome (PTS) is a common consequence and associated with impaired quality of life (QoL). The ExACT study was a non‐blinded, prospective, multicentred randomised controlled trial comparing extended versus limited duration anticoagulation following a first unprovoked VTE (proximal deep vein thrombosis or pulmonary embolism). Adults were eligible if they had completed ≥3 months anticoagulation (remaining anticoagulated). The primary outcome was time to first recurrent VTE from randomisation. The secondary outcomes included PTS severity, bleeding, QoL and D‐dimers. Two‐hundred and eighty‐one patients were recruited, randomised and followed up for 24 months (mean age 63, male:female 2:1). There was a significant reduction in recurrent VTE for patients receiving extended anticoagulation [2·75 vs. 13·54 events/100 patient years, adjusted hazard ratio (aHR) 0·20 (95% confidence interval (CI): 0·09 to 0·46, P < 0·001)] with a non‐significant increase in major bleeding [3·54 vs. 1·18 events/100 patient years, aHR 2·99 (95% CI: 0·81–11·05, P = 0·10)]. Outcomes of PTS and QoL were no different between groups. D‐dimer results (on anticoagulation) did not predict VTE recurrence. In conclusion, extended anticoagulation reduced VTE recurrence but did not reduce PTS or improve QoL and was associated with a non‐significant increase in bleeding. Results also suggest very limited clinical utility of D‐dimer testing on anticoagulated patients. |
| first_indexed | 2024-03-07T05:21:12Z |
| format | Journal article |
| id | oxford-uuid:defb2584-56e8-4c23-aeef-09929532078b |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:21:12Z |
| publishDate | 2019 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:defb2584-56e8-4c23-aeef-09929532078b2022-03-27T09:36:06ZA randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:defb2584-56e8-4c23-aeef-09929532078bEnglishSymplectic Elements at OxfordWiley2019Bradbury, CFletcher, KSun, YHeneghan, CGardiner, CRoalfe, AHardy, PMcCahon, DHeritage, GShackleford, HHobbs, FFitzmaurice, DVenous thromboembolism (VTE) is prevalent and impactful, with a risk of death, morbidity and recurrence. Post‐thrombotic syndrome (PTS) is a common consequence and associated with impaired quality of life (QoL). The ExACT study was a non‐blinded, prospective, multicentred randomised controlled trial comparing extended versus limited duration anticoagulation following a first unprovoked VTE (proximal deep vein thrombosis or pulmonary embolism). Adults were eligible if they had completed ≥3 months anticoagulation (remaining anticoagulated). The primary outcome was time to first recurrent VTE from randomisation. The secondary outcomes included PTS severity, bleeding, QoL and D‐dimers. Two‐hundred and eighty‐one patients were recruited, randomised and followed up for 24 months (mean age 63, male:female 2:1). There was a significant reduction in recurrent VTE for patients receiving extended anticoagulation [2·75 vs. 13·54 events/100 patient years, adjusted hazard ratio (aHR) 0·20 (95% confidence interval (CI): 0·09 to 0·46, P < 0·001)] with a non‐significant increase in major bleeding [3·54 vs. 1·18 events/100 patient years, aHR 2·99 (95% CI: 0·81–11·05, P = 0·10)]. Outcomes of PTS and QoL were no different between groups. D‐dimer results (on anticoagulation) did not predict VTE recurrence. In conclusion, extended anticoagulation reduced VTE recurrence but did not reduce PTS or improve QoL and was associated with a non‐significant increase in bleeding. Results also suggest very limited clinical utility of D‐dimer testing on anticoagulated patients. |
| spellingShingle | Bradbury, C Fletcher, K Sun, Y Heneghan, C Gardiner, C Roalfe, A Hardy, P McCahon, D Heritage, G Shackleford, H Hobbs, F Fitzmaurice, D A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) |
| title | A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) |
| title_full | A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) |
| title_fullStr | A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) |
| title_full_unstemmed | A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) |
| title_short | A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study) |
| title_sort | randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism vte and post thrombotic syndrome in patients being treated for a first episode of unprovoked vte the exact study |
| work_keys_str_mv | AT bradburyc arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT fletcherk arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT suny arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT heneghanc arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT gardinerc arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT roalfea arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT hardyp arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT mccahond arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT heritageg arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT shacklefordh arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT hobbsf arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT fitzmauriced arandomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT bradburyc randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT fletcherk randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT suny randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT heneghanc randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT gardinerc randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT roalfea randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT hardyp randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT mccahond randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT heritageg randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT shacklefordh randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT hobbsf randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy AT fitzmauriced randomisedcontrolledtrialofextendedanticoagulationtreatmentversusstandardtreatmentforthepreventionofrecurrentvenousthromboembolismvteandpostthromboticsyndromeinpatientsbeingtreatedforafirstepisodeofunprovokedvtetheexactstudy |